The U.S. Food and Drug Administration (FDA) has named Terns Pharmaceuticals’ investigational oral agent TERN-701 a breakthrough therapy for potential use in certain people…
Latest news & perspectives
Almost a third of people with advanced pancreatic cancer taking part in an ongoing clinical trial had stable disease following treatment with the experimental…
Discussion
Some days when I’m caregiving for my mum, I’ve noticed that the hardest part isn’t what one might expect. The hardest part doesn’t have anything…
